article thumbnail

Top 10 Most Environmentally Sustainable Pharma Companies in 2023/2024

XTalks

There was also significant variability in emissions, up to five times, between pharma companies with comparable revenues. For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products.

article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Life Sciences Trends for 2023

XTalks

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

article thumbnail

Large pharma companies support Women in STEM leadership pilot 

Drug Discovery World

The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment. Despite women making up 53% of the world’s STEM bachelor’s and master’s graduates, they still only account for around 30% of the world’s researchers. Context .

article thumbnail

The benefits of being a family-run pharma company

pharmaphorum

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

article thumbnail

The largest pharma company in Europe calls for interoperability

pharmaphorum

Data is readily shared and leveraged for decision-makers to gain insight that can help clinical research. Ehab graduated from Harvard Business school’s Executive General Management Programme in 2009 and holds a bachelor’s degree in Pharmaceutical Sciences. About the author .

article thumbnail

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins. This helps to reduce human error and provide more reliable, replicable results and increase the speed of drug discovery and development processes.